Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.52 Analyst target: $4.00 Upside: 664.67%
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.